PIDTC: Investigating Outcomes of Allogeneic Hematopoietic Cell Transplantation in Chronic Granulomatous Disease
23 feb 2024 ·
1 min. 43 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood on December 14, 2023, titled "Genotype, oxidase status,...
mostra di più
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood on December 14, 2023, titled "Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD."
Read the paper here: https://ashpublications.org/blood/article-abstract/142/24/2105/497415/Genotype-oxidase-status-and-preceding-infection-or?redirectedFrom=fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
mostra meno
Read the paper here: https://ashpublications.org/blood/article-abstract/142/24/2105/497415/Genotype-oxidase-status-and-preceding-infection-or?redirectedFrom=fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Informazioni
| Autore | RDCRN |
| Organizzazione | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
